NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Munafa technical analysis Sarepta Therapeutics, Inc. SRPT technical analysis buy or sell

Munafa technical analysis Sarepta Therapeutics, Inc. SRPT technical analysis buy or sell Analysis of Sarepta Therapeutics, Inc. SRPT to buy or sell for Daily, weekly or monthly

Quick Chart Bull Charts Forecast Tomorrow Price Targets View Analysis

Sarepta Therapeutics, Inc. SRPT Daily Analysis to buy or sell

As per my analysis of Sarepta Therapeutics, Inc. SRPT, 12 day returns for Sarepta Therapeutics, Inc. SRPT have been positive, with total returns of 6.39, which is 37.95% with investment starting at 16.84.
An investment of 100,000 bucks in Sarepta Therapeutics, Inc. would have become 137950 bucks today.

Sarepta Therapeutics, Inc. SRPT moves in a range of 1 points on a day to day basis. This means that a total of approx 1 plus points of returns can be expected in a bullish day, and a total of 1 minus points can be expected in a bearish day.
This is about 4.3% of returns per day.

Sarepta Therapeutics, Inc. Munafa analysis, looking for Trend and BUY or SELL opportunities.

Stock is in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Sarepta Therapeutics, Inc. SRPT at this time.

It appears as if Sarepta Therapeutics, Inc. SRPT gave a large move recently.

Stock of Sarepta Therapeutics, Inc. (SRPT) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might move higher!

Although my analysis for Sarepta Therapeutics, Inc. is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 24.2, for a target of 21.2 or 18.64

You can find more Price Targets here or Forecast here for Shortterm, Midterm, and Longterm

Daily Candle Stick analysis of Sarepta Therapeutics, Inc. SRPT

Candle stick analysis of Sarepta Therapeutics, Inc. as on 02 Thu Apr 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 9.8 HC: 0.3 LC: 9.5 OC: 6.4

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 01 Wed Apr 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 4.7 HC: 2.4 LC: 2.2 OC: 3.4

Sarepta Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 31 Tue Mar 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 6.7 HC: 1.6 LC: 5 OC: 6.7

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 30 Mon Mar 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 4.1 HC: 0.7 LC: 3.4 OC: 3.5

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 27 Fri Mar 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 9.9 HC: 8.5 LC: 1.3 OC: 0

Sarepta Therapeutics, Inc. is moving towards a low expiry

Sarepta Therapeutics, Inc. is forming a DOJI candle

Sarepta Therapeutics, Inc. SRPT Weekly Analysis to buy or sell

As per my analysis of Sarepta Therapeutics, Inc. SRPT, 12 week returns for Sarepta Therapeutics, Inc. SRPT have been positive, with total returns of 2.09, which is 9.89% with investment starting at 21.14.
An investment of 100,000 bucks in Sarepta Therapeutics, Inc. would have become 109890 bucks today.

Sarepta Therapeutics, Inc. SRPT moves in a range of 1.4 points on a week to week basis. This means that a total of approx 1.4 plus points of returns can be expected in a bullish week, and a total of 1.4 minus points can be expected in a bearish week.
This is about 6.03% of returns per week.

Weekly Candle Stick analysis of Sarepta Therapeutics, Inc. SRPT

Candle stick analysis of Sarepta Therapeutics, Inc. as on 02 Thu Apr 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 17.6 HC: 0.3 LC: 17.3 OC: 16.9

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 27 Fri Mar 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 43.1 HC: 19.4 LC: 19.8 OC: 40.9

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 20 Fri Mar 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 11.8 HC: 3.8 LC: 7.7 OC: 5

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 13 Fri Mar 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 8.1 HC: 8 LC: 0.1 OC: 4.8

Sarepta Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 06 Fri Mar 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 8.7 HC: 1 LC: 7.6 OC: 3.7

Sarepta Therapeutics, Inc. is moving towards a high expiry

Sarepta Therapeutics, Inc. SRPT Monthly Analysis to buy or sell

As per my analysis of Sarepta Therapeutics, Inc. SRPT, 12 month returns for Sarepta Therapeutics, Inc. SRPT have been negative, with total returns of -14.37, which is -38.22% with investment starting at 37.60.
An investment of 100,000 bucks in Sarepta Therapeutics, Inc. would have become 61780 bucks today.

Sarepta Therapeutics, Inc. SRPT moves in a range of 6.7 points on a month to month basis. This means that a total of approx 6.7 plus points of returns can be expected in a bullish month, and a total of 6.7 minus points can be expected in a bearish month.
This is about 28.84% of returns per month.

Monthly Candle Stick analysis of Sarepta Therapeutics, Inc. SRPT

Candle stick analysis of Sarepta Therapeutics, Inc. as on 02 Thu Apr 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 17.6 HC: 0.3 LC: 17.3 OC: 16.9

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 27 Fri Mar 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 53.9 HC: 19.4 LC: 28.8 OC: 46.5

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 27 Fri Feb 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 30.2 HC: 27.5 LC: 2.1 OC: 6.8

Sarepta Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 30 Fri Jan 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 22.8 HC: 21.3 LC: 1.2 OC: 13.2

Sarepta Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 26 Fri Dec 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 18.7 HC: 4 LC: 14.2 OC: 10.4

Sarepta Therapeutics, Inc. is moving towards a high expiry

Share on: WhatsApp Facebook Tweet